Literature DB >> 31669769

Bodyweight fluctuation and atrial fibrillation: A new risk factor?

Celine Gallagher1, Michael B Stokes1, Prashanthan Sanders1, Dennis H Lau2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31669769     DOI： 10.1016/j.hrthm.2019.10.023

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN： 1547-5271            Impact factor:   6.343


× No keyword cloud information.
  1 in total

1.  Sodium-glucose co-transporter 2 inhibition as a mitochondrial therapy for atrial fibrillation in patients with diabetes?

Authors:  Salva R Yurista; Herman H W Silljé; Michiel Rienstra; Rudolf A de Boer; B Daan Westenbrink
Journal:  Cardiovasc Diabetol       Date:  2020-01-07       Impact factor: 9.951
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.